In a significant development a jury in California jury found Bayer’s Roundup weedkiller was not the cause of a woman’s non-Hodgkin’s lymphoma, said Bayer in a statement. The verdict marks the second such victory in court for the chemical giant… Read More ›
Bayer
European Court of Justice upholds partial ban on Bayer’s pesticides linked to death of bees
In a landmark ruling on Thursday, the European Union’s top court upheld the EU’s partial ban on three insecticides linked to harming of bees, thus extending their usage on certain crops. Dismissing an appeal by Bayer, the European Court of… Read More ›
Bayer’s $11 billion Roundup settlement provision rises by $750M
In a statement, German chemicals and pesticides giant Bayer stated, the costs of settlement over claims of its Roundup weedkiller which causes cancer, which it had initially placed at $11 billion, will go up further by $750 million. Although earlier this… Read More ›
Elanco Animal Health acquires Bayer’s veterinary drugs business for $7.6 billion
The cash and stock deal will see Elanco becoming the world’s second biggest animal health company and expand its footprint in the pet e-commerce space. On Tuesday, Elanco Animal Health stated it would acquire Bayer’s veterinary drugs business in what… Read More ›
Bayer proposes to pay $8 billion to settle 18,000 U.S. lawsuits over Monsanto’s Roundup weedkiller
Bayer’s strategic could potentially significantly reduce headwinds revolving around lawsuits stemming from Monsanto’s glyphosate-based weedkiller – Roundup. On Friday, shares of Bayer surged by 11% following a report from Bloomberg that it has proposed to pay $8 billion in order… Read More ›
Bayer to invest $5.6 billion in new weed killer
It appears that Bayer intends on creating another line of weedkillers other than Monsanto’s RoundUp, which is causing it lots of grief stemming from thousands of U.S. lawsuits. RoundUp contains glyphosate, which according to plaintiffs, causes cancer. On Friday, in… Read More ›
Lawsuits from Monsanto’s weedkiller Roundup haunts Bayer
Bayer is likely to face negative investor sentiments on Friday at its AGM on the way its management team handled the $63 billion Monsanto deal. According to two sources familiar with the matter at hand, BlackRock will not support Bayer’s… Read More ›
Bayer gets Russia’s nod for its $66 billion acquisition of Monsanto
Bayer has already received approval from the EU, Australia, Brazil, China; Russia now adds to this list. In a development that aids Bayer’s $66 billion acquisition of Monsanto, it has now got approval from FAS, Russia’s antitrust regulator, for its… Read More ›
Bayer gets antitrust approval from U.S. Justice Department for its $62.5 billion acquisition of Monsanto
The combined company will control more than a quarter of the world’s seed and pesticide market. With the U.S. Justice Department giving the green signal to Bayer AG’s bid to acquire Monsanto Co for $62.5 billion deal, with both companies… Read More ›
Bayer snags EU’s antitrust approval for its $62.5 billion acquisition of Monsanto
While Bayer has already received approval from Brazil and conditional approval from China, its acquisition of its peer Monsanto is currently awaiting review by Russian and U.S antitrust authorities. In the latest mega mergers that will reshape the agrochemicals industry,… Read More ›